Endometrial cancer doesn't stay silent for long, which is why recognising the red flags early is critical.

A study of 162,500 patients with uterine cancer found that survival rates varied significantly by race and geographic location, with Black patients experiencing the worst survival outcomes in areas ...

Many women can name the warning signs of breast cancer or colon cancer-but what about uterine cancer? It's the sixth most common type of cancer in women, per the International Gynecologic Cancer ...

Adding the PD-1 inhibitor dostarlimab to standard chemotherapy provides sustained survival benefits for patients with deficient mismatch repair (dMMR)/microsatellite instability-high (MSI-H) advanced ...

The conversation often begins with subtle changes that women might initially dismiss as normal variations in their monthly cycle. Perhaps unusual bleeding between periods, or discharge that seems ...

Tecentriq addition showed no significant OS benefit in advanced/recurrent endometrial cancer, except in dMMR patients with improved survival outcomes. PFS outcomes numerically favored Tecentriq across ...

In January, the American Cancer Society reported that for the first time women younger than 50 had a higher cancer incidence rate than men. Based on 2023 data, cancer incidence rates among women under ...

African-American women with uterine cancer have worse survival rates than Caucasian women who received similar treatment even though they had similar prognostic factors, according to a new review of ...

During this Gynecological Cancer Awareness Month, GSK Canada is launching the inaugural Endometrial Cancer Awareness Week, an education-focused initiative in collaboration with oncology and patient ...